HIV/AIDS Clinical Trials

HIV Prevention for PLHIV: Evaluation of an Intervention Toolkit for HIV Care & Treatment Settings

Condition: HIV

NCT ID: NCT01256463

Highly Active Antiretroviral Therapy (HAART) Adherence Interventions

Condition: HIV Infections

NCT ID: NCT00273780

The Aim of This Study is to Determine the Effectiveness of a Motivational Enhancement Intervention in Reducing Risk Behaviors (Drug and Alcohol Use, Sexual Risk Behavior, Poor Adherence to Medications) Among HIV+ Youth. - 1

Condition: Adherence; HIV Risk Behaviors; Alcohol & Drug Use; Health Behaviors; Sexual Risk Behaviors

NCT ID: NCT00227825

Reducing Heavy Drinking to Optimize HIV/AIDS Treatment and Prevention

Condition: Reduction in Heavy Drinking in Patients With HIV

NCT ID: NCT01227044

Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice

Condition: HIV Infections

NCT ID: NCT01524900

A Spanish-Language Intervention to Enhance Routine HIV Patient Care Delivery [CARE+ Spanish]

Condition: HIV Infections

NCT ID: NCT01013935

A Medication Adherence Intervention for HIV Infected Veterans

Condition: HIV Infection

NCT ID: NCT00013065

Behavioral Intervention to Enhance HIV Test/Treat

Condition: HIV/AIDS

NCT ID: NCT01752777

The Mochudi Prevention Project ART Protocol

Condition: HIV Infections

NCT ID: NCT01583439

Evaluation of an Intervention on Adherence to Highly Active Antiretroviral Therapy (HAART) in HIV Infected Adults

Condition: HIV Infections

NCT ID: NCT00203853

Effectiveness of Coping Training for People With HIV Experiencing Treatment Side Effects (The Balance Project)

Condition: HIV Infections

NCT ID: NCT00643903

Factors Affecting Adherence to Anti-HIV Drug Regimens in Children and Adolescents

Condition: HIV Infections

NCT ID: NCT00073424

DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects

Condition: HIV

NCT ID: NCT01423812

A Study of an Adherence Plan to Help HIV-Positive Patients Take Their First Anti-HIV Medications Correctly

Condition: HIV Infections

NCT ID: NCT00001122

Self-Managing HIV and Chronic Disease

Condition: HIV/AIDS

NCT ID: NCT01032824

Effects of Home Visits on Medication Adherence in Children and Youth With HIV

Condition: HIV Infections

NCT ID: NCT00006439

Enhancing Communication and HIV Outcomes

Condition: HIV Infections

NCT ID: NCT00675610

Start TB Patients on ART and Retain on Treatment (START Study)

Condition: Tuberculosis; HIV

NCT ID: NCT01872390

Stress-Reducing Interventions in HIV+ Patients: Pilot

Condition: Stress Disorders, Post-Traumatic; HIV Infections

NCT ID: NCT00599599

Tenofovir, Emtricitabine and Efavirenz Late Switch to a Single Pill: Patients' Opinion Survey

Condition: HIV Infection

NCT ID: NCT01322932

Music for Health Project

Condition: Human Immunodeficiency Virus

NCT ID: NCT01786148

Enhanced Access to HIV Care for Drug Users in San Juan, Puerto Rico

Condition: HIV; AIDS; Substance Abuse

NCT ID: NCT01792752

HEART to HAART: Smartphone Intervention to Improve HAART Adherence for Drug Users

Condition: HIV; Drug Use Disorders

NCT ID: NCT01413529

CVCTPlus: A Couples-Based Approach to Linkage to Care and ARV Adherence

Condition: HIV

NCT ID: NCT01772992

Treatment for Depression Among HIV-Infected Youth

Condition: HIV; Depression; HIV Infections

NCT ID: NCT01049789

Positive Lifestyles Using Safety

Condition: HIV; HIV Infections

NCT ID: NCT00836290

Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805)

Condition: Acute HIV Infection; HIV Infections

NCT ID: NCT00924898

Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIV

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT01433185

Cognitive Behavioral Stress Management for HIV+ Drug Abusers

Condition: HIV/AIDS; Drug Abuse; Alcohol Abuse

NCT ID: NCT00722644

An Expanded Safety Study of Dapivirine Gel 4789 in Africa

Condition: HIV Infections; Acquired Immunodeficiency Syndrome; Healthy

NCT ID: NCT00917904

An Expanded Safety Study of Dapivirine Gel 4759 in Africa

Condition: HIV Infections; Acquired Immunodeficiency Syndrome

NCT ID: NCT00917891

Raltegravir Use as Nonoccupational Postexposure Prophylaxis (NPEP) in Men Who Have Sex With Men

Condition: HIV Prevention; HIV Infections

NCT ID: NCT01087840

Evaluation of a Tailored Virtual Intervention to Empower Persons Living With HIV for Therapy Self-management

Condition: HIV

NCT ID: NCT01510340

An Educational and Supportive Counseling Program for Increasing Antiretroviral Use and Adherence in People With HIV

Condition: HIV

NCT ID: NCT00611429

Safety Study of Once a Day ART and Opiate Substitute.

Condition: HIV Infections

NCT ID: NCT00324688

Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program

Condition: Human Immunodeficiency Virus Infection

NCT ID: NCT01662336

A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure

Condition: HIV-1 Infection

NCT ID: NCT01641367

Integrated Treatment of Marijuana Abuse for HIV+ Youth

Condition: HIV Infections

NCT ID: NCT00683488

Treatment Perception of QD (Once a Day) Dosed Kaletra (Tablets)

Condition: Human Immunodeficiency Virus Infection

NCT ID: NCT01383005

Home-based AIDS Care Project

Condition: HIV Infections

NCT ID: NCT00119093

PI or NNRTI as First-line Treatment of HIV in West Africa - the PIONA Trial

Condition: HIV-1

NCT ID: NCT01192035

Understanding Medication Adherence Among HIV Patients

Condition: Patient Commitment Preferences for Medication Adherence

NCT ID: NCT01305590

Once Daily 3TC, Efavirenz and ddI for HIV Infection

Condition: HIV Infection; AIDS

NCT ID: NCT00214435

Therapeutic Drug Monitoring and Viral Resistance Testing in the Treatment of HIV-Infected Children

Condition: HIV Infections

NCT ID: NCT00032669

SWEET: Once Daily Truvada Versus Twice Daily Combivir for the Treatment of HIV Infection

Condition: HIV Infections

NCT ID: NCT00323544

Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected Adults in Senegal

Condition: HIV Infections

NCT ID: NCT00100568

Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child Transmission

Condition: HIV Infections; Pregnancy Complications, Infectious

NCT ID: NCT00028145

The First Failure Study

Condition: HIV; HIV Infections

NCT ID: NCT01118871

Atazanavir or Lopinavir in HIV Post-exposure Prophylaxis

Condition: HIV Infections

NCT ID: NCT00385645

Extending HIV Care Beyond the Rural Health Center

Condition: HIV; HIV Infections

NCT ID: NCT00371540

The PeerCARE Study (Peer Community-based Assistant in REtention)

Condition: HIV

NCT ID: NCT01366690

SANKOFA Pediatric HIV Disclosure Intervention

Condition: HIV

NCT ID: NCT01701635

CCTG 595: Text Messaging Intervention to Improve Adherence to PrEP in High-risk MSM

Condition: Patient Adherence; HIV Seronegativity

NCT ID: NCT01761643

Boosted Atazanavir and Truvada Given Once-Daily - BATON Study

Condition: HIV Infections

NCT ID: NCT00224445

An Automated, Tailored Information Application for Medication Health Literacy

Condition: Human Immunodeficiency Virus I Infection

NCT ID: NCT01304186

Behavioral Depression Treatment for African American HIV-infected Substance Users

Condition: Major Depressive Disorder; Substance Use

NCT ID: NCT01351454

Treatment Options for Protease Inhibitor-exposed Children

Condition: HIV/AIDS; HIV Infections

NCT ID: NCT01146873

Cameroon Mobile Phone SMS Trial

Condition: Adherence; HIV

NCT ID: NCT01247181

Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men

Condition: Stimulant-Related Disorders; HIV; HIV Infections

NCT ID: NCT01140880

A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL

Condition: Lymphoma, AIDS Related; HIV Infections

NCT ID: NCT00799136

Body Image and Self-Care in HIV-Infected MSM

Condition: Body Image Disturbance; Medication Adherence

NCT ID: NCT01817621

Microbicides Acceptability Among Sexually Active Young Women

Condition: HIV Infections

NCT ID: NCT00490152

Centralized Off-Site Adherence Enhancement Program

Condition: HIV/AIDS

NCT ID: NCT01409655

A Mindfulness Based Approach to HIV Treatment Side Effects

Condition: HIV Infections

NCT ID: NCT00312936

Engaging Care for HIV-Infected Adolescent Females.

Condition: HIV Infection

NCT ID: NCT00489034

HIV Treatment-Readiness Measure (HTRM) Validation

Condition: HIV Infections

NCT ID: NCT00686049

HIV Counseling and Testing and Linkage to Care in Uganda

Condition: HIV Infections

NCT ID: NCT00648232

Directly Observed Antiretroviral Therapy Among Active Drug Users

Condition: HIV/AIDS; Substance Abuse

NCT ID: NCT00367172

The Treatment of Insomnia in Patients With HIV Disease

Condition: HIV Infections; Insomnia

NCT ID: NCT00465972

LINFOTARGAM: Treatment With Chemotherapy Plus Rituximab and Highly Active Antiretroviral Therapy in Patients With Diffuse Large B Cell Lymphoma and Infection With the Human Immunodeficiency Virus (HIV)

Condition: HIV Infections; Diffuse Large B Cell Lymphoma

NCT ID: NCT00466258

CARE Corrections: Technology for Jail HIV/HCV Testing, Linkage, and Care (TLC)

Condition: Human Immunodeficiency Virus

NCT ID: NCT01721226

Biomarkers of Protocol Compliance and Product Adherence

Condition: HIV Prevention

NCT ID: NCT01804023

Treating Chronic Pain and Depression in HIV+ Patients in Primary Care Settings

Condition: Pain Interference; Depression; Antiretroviral Adherence

NCT ID: NCT01735708

Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age

Condition: HIV Infections

NCT ID: NCT01127204

The Efficacy of the HIV/AIDS Symptom Management Manual

Condition: HIV; Acquired Immunodeficiency Syndrome

NCT ID: NCT00241202

Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive Patients

Condition: Hiv Infection With Antiretroviral Therapy Indication; CD4 Below 350/µL or Below 15%

NCT ID: NCT00199979

Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected Adults

Condition: HIV Infections; Antiretroviral Naive

NCT ID: NCT00196599

Evaluation of Behavioral Intervention for HIV Positive Prisoners in NC and TX

Condition: HIV Infection

NCT ID: NCT01629316

Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART

Condition: HIV Infections

NCT ID: NCT00196612

Evaluation of Three Strategies of Second-line Antiretroviral Treatment in Africa (Dakar - Bobo-Dioulasso - Yaoundé)

Condition: HIV; HIV Infections

NCT ID: NCT00928187

Combination of Efavirenz and Truvada - COMET Study

Condition: HIV Infections

NCT ID: NCT00224458

Buprenorphine and Integrated HIV Care

Condition: Substance-Related Disorders; Drug Addiction; Human Immunodeficiency Virus; AIDS; HIV Infections

NCT ID: NCT00317460

A Trial to Compare Raltegravir Versus Nevirapine as Anchor Drug for HIV+ Chinese IDUs on Methadone Maintenance

Condition: HIV; HIV Infections

NCT ID: NCT01042652

Clinical Trial to Reduce Drinking in Women With HIV

Condition: HIV Infection

NCT ID: NCT01625091

Use of Incentives to Retain Drug Users in HIV Therapy

Condition: HIV Infection

NCT ID: NCT01488942

DART I - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

Condition: HIV Infections; AIDS

NCT ID: NCT00116415

SCOPE: Strategies to Combine PrEP With Prevention Efforts

Condition: HIV

NCT ID: NCT01832571

DART II - A Phase IV Study of 3 Antiretroviral Medicines in Combination, in HIV Patients Who Have Not Been Previously Treated With Antiretroviral Therapy

Condition: HIV Infections; AIDS

NCT ID: NCT00116116

Skills Based Counseling for Adherence and Depression in HIV+ Methadone Patients - 1

Condition: Adherence; Depression; Heroin Dependence; Methadone; Motivational Interviewing; Substance-Related Disorders

NCT ID: NCT00218634

Evaluating the Safety and Effectiveness of Short-Course Rifapentine/Isoniazid for the Prevention of Active Tuberculosis in HIV-Infected Individuals With Latent Tuberculosis Infection

Condition: Tuberculosis; HIV Infections

NCT ID: NCT01404312

BREATHER (PENTA 16) Short-Cycle Therapy (SCT) (5 Days on/2 Days Off) in Young People With Chronic HIV-infection

Condition: HIV

NCT ID: NCT01641016

HPTN 073 Black Men Who Have Sex With Men (MSM) Pre-Exposure Prophylaxis (PrEP)

Condition: HIV

NCT ID: NCT01808352

KONCERT A Kaletra ONCE Daily Randomised Trial of the Pharmacokinetics, Safety and Efficacy of Twice-daily Versus Once-daily Lopinavir/Ritonavir Tablets Dosed by Weight as Part of Combination Antiretroviral Therapy in Human Immunodeficiency Virus-1 (HIV-1) Infected Children (PENTA 18)

Condition: Antiretroviral Therapy in HIV-1 Infected Children

NCT ID: NCT01196195

Botswana TDF/FTC Oral HIV Prophylaxis Trial

Condition: HIV Infections

NCT ID: NCT00448669

Testing and Linkage to Care for Injecting Drug Users in Kenya

Condition: HIV Infection

NCT ID: NCT01557998

Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment

Condition: HIV; Opiate Dependence

NCT ID: NCT01376570

Bangkok Tenofovir Study

Condition: HIV Infections

NCT ID: NCT00119106

Study Switching HIV-1 Infected Patients With an Undetectable Viral Load on a First Protease Inhibitor-Based Regimen to an Efavirenz-Based Regimen

Condition: HIV Infections

NCT ID: NCT00135382

A Knowledge Translation Intervention for TB/HIV Treatment Adherence, in Zomba District, Malawi

Condition: Tuberculosis

NCT ID: NCT01356095

Metabolic Safety of Raltegravir Versus Darunavir in HIV Naive Patients

Condition: Cardiovascular Disease; HIV Infections

NCT ID: NCT01066065

HIV and Hepatitis Care Coordination in Methadone Treatment

Condition: Hepatitis, Viral, Human; HIV Infections

NCT ID: NCT00608192

Managerial Database II

Condition: HIV

NCT ID: NCT01009827

Will Having Alcohol Treatment Improve Functioning?

Condition: HIV; Alcoholism

NCT ID: NCT01245647

A Study on Antiretroviral Therapy (ART) Naïve Patients On Different Regimens to Treat Hiv (NORTHIV)

Condition: HIV

NCT ID: NCT01445223

TDF Long Term Study

Condition: HIV-infected Thai Children

NCT ID: NCT01815255

Aripiprazole Treatment for Methamphetamine Dependence Among High-risk Individuals

Condition: Substance Abuse; HIV Infections

NCT ID: NCT00497055

Acceptability of Pharmacologic Treatment for Methamphetamine Dependence Among MSM

Condition: Substance Abuse; HIV Infections

NCT ID: NCT00318409

Assessment of Pre-Exposure Prophylaxis (PrEP) Administered at Sexually Transmitted Disease (STD) Clinics

Condition: HIV Infections

NCT ID: NCT01632995

Behavioral Intervention Trial for HIV-infected Injection Drug Users

Condition: HIV

NCT ID: NCT00146445

Seek, Test, Treat Strategies for Vietnamese Drug Users: A Randomized Controlled Trial

Condition: HIV; Addiction

NCT ID: NCT01841320

An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis

Condition: HIV Infection

NCT ID: NCT01772823

Pregnant Women's CoOp

Condition: HIV

NCT ID: NCT00722670

Home Assessment and Initiation of Antiretroviral Therapy for HIV in Malawi

Condition: HIV

NCT ID: NCT01414413

An Open Label Demonstration Project and Phase II Safety Study of Pre-Exposure Prophylaxis Use Among 15 to 17 Year Old Young Men Who Have Sex With Men (YMSM)

Condition: HIV Infection

NCT ID: NCT01769456

Intervention to Improve Engagement in Care Among Newly Diagnosed HIV-positive Men

Condition: HIV; Patient Compliance

NCT ID: NCT01559805

Promoting Male Involvement to Improve Prevention of Mother to Child Transmission (PMTCT) Uptake and Reduce Antenatal Infection

Condition: HIV; Pregnancy

NCT ID: NCT01448512

Complementary & Alternative Medicine Use in HIV+ Latinos in the US-Mexico Border

Condition: HIV Positive

NCT ID: NCT01152684

Adolescent Impact: A Behavioral Intervention for Adolescents Living With HIV/AIDS

Condition: HIV Infections

NCT ID: NCT00164385

Trial of Cognitive Behavioral Therapy to Reduce Antiretroviral Therapy Side Effects

Condition: HIV Infections; Adverse Effects

NCT ID: NCT00696839

Treatment Effects of Escitalopram (Lexapro®) on Generalized Anxiety Disorder in Patients With HIV and AIDS

Condition: Anxiety Disorders; HIV Infections

NCT ID: NCT00887679

Carolina Alcohol and Drug Resources

Condition: HIV

NCT ID: NCT01791179

The Effect of Teaching HIV-Infected Patients About HIV and Treatment

Condition: HIV Infections

NCT ID: NCT00002409

Anti-HIV Drug Regimens With or Without Protease Inhibitors and Drug Level Monitoring in HIV Infected Adolescents

Condition: HIV Infections

NCT ID: NCT00075907

Contingency Management in the Delivery of HAART to Drug Users in Chennai, India

Condition: HIV; Substance Abuse, Intravenous

NCT ID: NCT01031745

Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients

Condition: Hepatitis C; Depressive Disorder, Major; Depressive Disorder; Depression; HIV Infections

NCT ID: NCT00655226

Telephone Based Cognitive Behavioral Therapy for HIV Related Depression

Condition: Depression; HIV Infections

NCT ID: NCT01055158

Behavioral, Clinical and Basic Science Studies of Non-Occupational Post-Exposure Prophylaxis ("PEP-2")

Condition: HIV Infections

NCT ID: NCT00473018

HIV Translating Initiatives for Depression Into Effective Solutions

Condition: HIV; Depression

NCT ID: NCT00304915

Managerial Database II

Condition: Acquired Immunodeficiency Syndrome

NCT ID: NCT01322217

Longitudinal Pediatric Palliative Care: Quality of Life & Spiritual Struggle

Condition: HIV

NCT ID: NCT01289444

Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1

Condition: HIV-1 Infection; HIV Infections

NCT ID: NCT00993148

Brief Therapy Intervention for Heavy/Hazardous Drinking in HIV-Positive Women

Condition: HIV Infections; Alcoholism

NCT ID: NCT00127231

Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Resource-Limited Countries

Condition: HIV Infections

NCT ID: NCT01061151

Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel

Condition: HIV

NCT ID: NCT01687218

Safety Of VIRACEPT® 625mg Administered To HIV-Infected Women During Pregnancy

Condition: HIV Infection

NCT ID: NCT00246610

Safety and Efficacy of Reduced Dose Efavirenz (EFV) With Standard Dose EFV Plus Two Nucleotide Reverse Transcriptase Inhibitors (N(t)RTI) in Antiretroviral-naïve HIV-infected Individuals.

Condition: HIV Infections

NCT ID: NCT01011413

Outcomes for Antiretroviral Therapy Patients Receiving Palliative Care

Condition: HIV

NCT ID: NCT01608802

When to Start Anti-HIV Drugs in Patients With Opportunistic Infections

Condition: HIV Infections; AIDS-Related Opportunistic Infections

NCT ID: NCT00055120

Evaluating the Safety and Tolerability of Antiretroviral Drug Regimens Used as Pre-Exposure Prophylaxis to Prevent HIV Infection in Men Who Have Sex With Men and in At-Risk Women

Condition: HIV Infection

NCT ID: NCT01505114

A Study to Evaluate the Pharmacokinetics, Safety, Tolerability, and Antiviral Efficacy of TMC278 in Human Immunodeficiency Virus Infected Adolescents

Condition: Human Immuno Deficiency (HIV) Infections

NCT ID: NCT00799864

Trial Evaluating a First Line Combination Therapy With Raltegravir, Emtricitabine and Tenofovir in HIV-2 Infected Patients

Condition: HIV-2 Infection

NCT ID: NCT01605890

Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV

Condition: HIV Infections

NCT ID: NCT00035932

Central Nervous System Disease in HIV-infected Children on HAART

Condition: HIV Infections; Central Nervous System Diseases

NCT ID: NCT00110331

Effectiveness of Peer Navigation to Link Released HIV+ Jail Inmates to HIV Care

Condition: HIV-infection/Aids

NCT ID: NCT01406626

Study Of An Investigational Regimen Including FDA Approved HIV Drugs In HIV-Infected Pediatric Subjects

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT00071760

Neurocognitive Assessment in Youth Initiating HAART

Condition: HIV Infections

NCT ID: NCT00683579

Home-based Partner Education and Testing (HOPE) Study

Condition: HIV

NCT ID: NCT01784783

Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected Children

Condition: Tuberculosis

NCT ID: NCT00330304

HIV Prevention and Care of Psychological Trauma in Vulnerable Rwandan Youth

Condition: Acquired Immunodeficiency Syndrome; Stress Disorders, Post-Traumatic

NCT ID: NCT01401335

Not yet recruiting(En español)

Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant Women

Condition: HIV Infections

NCT ID: NCT01490671

Validation of System for Monitoring the Effectiveness of Antiretroviral Therapy in HIV-Infected Patients in Africa

Condition: HIV

NCT ID: NCT00341393

Shamba Maisha: Pilot Agricultural Intervention for Food Security and HIV Health Outcomes in Kenya

Condition: HIV; Malnutrition

NCT ID: NCT01548599

Determining Characteristics and Behaviors of Adolescent Women Regarding HIV Risk and Microbicide Trial Participation

Condition: HIV Infections

NCT ID: NCT00872261

Seek, Test, Treat, Retain: An Integrated Jail-Prison-Community Model for Illinois

Condition: HIV Infections

NCT ID: NCT01852877

Buprenorphine HIV Care Integration Project

Condition: HIV Infection; Opioid-Related Disorders

NCT ID: NCT00348868

The ADAPT Study: Use of Emtricitabine and Tenofovir Disoproxil Fumarate for Pre-Exposure Prophylaxis (PrEP)

Condition: HIV Infections

NCT ID: NCT01327651

Evaluating Strategies to Reduce Mother-to-Child Transmission of HIV Infection in Populations Using Formula Feeding (PROMISE)

Condition: HIV

NCT ID: NCT01253538

A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation

Condition: HIV Infections

NCT ID: NCT00036452

Feasibility of Non-pharmacological Insomnia Therapy in People Living With HIV

Condition: Insomnia; Sleep Efficiency

NCT ID: NCT01804907

Atripla to Raltegravir Switch Study

Condition: HIV Infection

NCT ID: NCT01195467

Kaletra and Viread in Antiretroviral Naïve Patients

Condition: HIV Infections

NCT ID: NCT00679926

An Electronic Pillbox for People With HIV

Condition: HIV Infections

NCT ID: NCT00071500

Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings

Condition: HIV Infections

NCT ID: NCT00084136

48-Week Study Of GW433908 And Ritonavir Or GW433908 Alone, Twice Daily In Pediatric Patients With HIV Infection

Condition: Infection, Human Immunodeficiency Virus I

NCT ID: NCT00089583

Buprenorphine and Integrated HIV Care Evaluation

Condition: Opioid-Related Disorders; HIV Infections; AIDS

NCT ID: NCT00124358

Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00365612

Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM)

Condition: Buprenorphine; HIV; Drug Abuse; Drug Addiction; Drug Dependence; Drug Use Disorders; Drug Use Disorder; Substance Abuse; Opiate Addiction; Substance-Related Disorders

NCT ID: NCT00798538

Neighborhood Alcohol & HIV Prevention in South African Townships (Philani)

Condition: Fetal Alcohol Syndrome; HIV; Nutrition Disorders

NCT ID: NCT00996528

Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors

Condition: Substance Abuse; HIV Infections

NCT ID: NCT00497081

Feasibility and Pilot Efficacy of Flash-heated Breast Milk to Reduce Maternal-to-Child-Transmission of HIV in Tanzania

Condition: HIV Infections

NCT ID: NCT00523510

Palliative Care in People Living With HIV/AIDS: Integrating Into Standard of Care

Condition: HIV

NCT ID: NCT01775436

Not yet recruiting(En español)

A Study to Evaluate the Use of a Protease Inhibitor and of Interleukin-2 (IL-2) in the Treatment of Early HIV Infection

Condition: HIV Infections

NCT ID: NCT00006154

Test of an Intervention to Improve HIV Care

Condition: HIV Infection

NCT ID: NCT01103856

Housing and Health Study

Condition: HIV; AIDS

NCT ID: NCT00153504

Raltegravir as Early Therapy in African-Americans Living With HIV Study

Condition: HIV Infections

NCT ID: NCT00667433

A Parenting and Self-Care Intervention for HIV Infected Mothers

Condition: HIV

NCT ID: NCT01586988

Treatment of HIV/HCV Coinfection With Peg-IFN and Ribavirin in Patients Receiving ART Monotherapy With Lopinavir/r

Condition: HIV/HCV Co-infection; HIV Infections

NCT ID: NCT00866021

HIV/AIDS Kaposis Sarcoma: Comparison of Response to HAART vs HAART Plus CXT

Condition: HIV; AIDS; Kaposi's Sarcoma; Human Herpesvirus 8

NCT ID: NCT00380770

Study of Impacts of Food Supplementation on Malnourished HIV-Infected Adults in Kenya

Condition: HIV; Malnutrition; HIV Infections

NCT ID: NCT00838292

Linkage to Care - Part I

Condition: HIV

NCT ID: NCT00703040

Multicentric Trial Comparing Three Therapeutical Strategies in Patients With Acute Primary HIV Infection

Condition: HIV Infections; Primary Acute Infection

NCT ID: NCT00196638

Clinical Trial Assessing Once Daily Raltegravir Administration (800 mg QD) in HIV-1-Infected Patients Receiving Unboosted Atazanavir (400 mg QD)- Based Antiretroviral Therapy

Condition: HIV Infections

NCT ID: NCT00718536

Effects of Contingency Management for Methamphetamine Abstinence on Post-Exposure Prophylaxis for HIV in Men Who Have Sex With Men (MSM)

Condition: Amphetamine-Related Disorders; HIV; HIV Infections

NCT ID: NCT00856323

HealthCall:Brief Intervention to Reduce Non-injecting Drug Use in HIV Primary Care Clinics

Condition: Behavioral Disorders Due to Psychoactive Substance Use

NCT ID: NCT01312181

A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination

Condition: HIV

NCT ID: NCT00335270

Safety of Raltegravir When Given as Part of HIV Therapy in HIV/HCV Coinfected Individuals

Condition: HIV/ Hepatitis C Co-Infection

NCT ID: NCT01147107

On Demand Antiretroviral Pre-exposure Prophylaxis for HIV Infection in Men Who Have Sex With Men

Condition: HIV Infection

NCT ID: NCT01473472

Evaluation of a Lopinavir/Ritonavir Monotherapy vs a Triple Therapy as Maintenance Regimens in HIV-1 Infected Patients

Condition: HIV Infections

NCT ID: NCT00946595

Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis

Condition: HIV Infections

NCT ID: NCT00402454

Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses

Condition: HIV Infections

NCT ID: NCT00460382

Effects of Uridine Supplementation on Metabolic Side Effects of Stavudine and Zidovudine

Condition: HIV Infections; Insulin Resistance; Hyperlactatemia

NCT ID: NCT00471614

Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load

Condition: HIV Infections

NCT ID: NCT00454337

Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients

Condition: HIV Infections

NCT ID: NCT00082498

Immune-based Therapy Pilot Study for the Treatment of Primary HIV Infection With the Objective to Induce a Strong Specific HIV Immune Response Able to Control Viral Replication Without Highly Active Anti-Retroviral Therapy (HAART)

Condition: HIV

NCT ID: NCT00979706

Management of Hepatitis C in HIV-Infected and Uninfected IDUs

Condition: Hepatitis C Virus; HIV Infections

NCT ID: NCT00496912

Assessing Short and Long Term Compliance With Caloric Intake in HIV Positive Women Taking Complera

Condition: HIV-1 Infection

NCT ID: NCT01701895

Preventing Sexual Transmission of HIV With Anti-HIV Drugs

Condition: HIV Infections

NCT ID: NCT00074581

Project RETAIN: Providing Integrated Care for HIV-Infected Crack Cocaine Users

Condition: HIV; AIDS; Substance Abuse

NCT ID: NCT01614106

Botswana Tenofovir Oral HIV Prophylaxis Trial

Condition: HIV Infection

NCT ID: NCT00111150

Acyclovir to Treat Patients Co-infected With HIV and Herpes Viruses in Uganda

Condition: HIV Infections; Herpes Genitalis

NCT ID: NCT00405821

The Treatment Advocacy Program

Condition: HIV

NCT ID: NCT00164333

Pilot Study Switching Individuals Receiving EFV With Continuing Central Nervous System Toxicity to TMC125

Condition: HIV

NCT ID: NCT00792324

Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00495651

Impact of Immediate Versus WHO Recommendations Guided ART Initiation on HIV Incidence - Feasibility Phase

Condition: HIV Infection

NCT ID: NCT01509508

Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01641809

Antiretroviral Therapy for Acute HIV Infection

Condition: Acute HIV Infection

NCT ID: NCT00796263

Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00115609

Efficacy of Simplified Two Drug Kaletra Regimen vs. Kaletra Triple Drug Standard of Care Regimen in Treatment naïve HIV Infected Patients

Condition: HIV Infection

NCT ID: NCT00234910

A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy

Condition: HIV Infections

NCT ID: NCT00102206

Fosamprenavir Versus Other Protease Inhibitors

Condition: Human Immunodeficiency Virus I Infection; HIV Infection

NCT ID: NCT00094523

Study to Evaluate the Activity and Tolerability of Lopinavir/Ritonavir and Lamivudine Bitherapy in HIV Patients With Viral Suppression

Condition: HIV Infection

NCT ID: NCT01471821

Antiretroviral Switch From Didanosine to Tenofovir in HIV/HCV Co-infected Patients

Condition: HIV; HIV Infections

NCT ID: NCT00358696

Directly Administered HIV Therapy in Methadone Clinics

Condition: HIV Infections; Heroin Dependence

NCT ID: NCT00279110

A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services

Condition: HIV Prevention

NCT ID: NCT01781806

Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)

Condition: HIV Infections

NCT ID: NCT00660972

Evaluating Methods to Increase HIV Testing, Access to HIV Care, and HIV Prevention Strategies

Condition: HIV Infection

NCT ID: NCT01152918

Trizivir Vs. Kaletra and Combivir for the Prevention of Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00270296

TMC278-TiDP6-C209: A Clinical Trial in Treatment Naive HIV-1 Patients Comparing TMC278 to Efavirenz in Combination With Tenofovir + Emtricitabine.

Condition: HIV Infections; HIV-1; Human Immunodeficiency Virus Type 1

NCT ID: NCT00540449

Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples

Condition: HIV-1 Infections; HIV Infections

NCT ID: NCT00557245

Comparison of HIV Clinic-Based Treatment With Buprenorphine Versus Referred Care in Heroin-Dependent Participants

Condition: Opiate Dependence; HIV Seropositivity; HIV Infections

NCT ID: NCT00130819

Mobile Phone Technology for Prevention of Mother-to-Child Transmission of HIV: Acceptability, Effectiveness, and Cost

Condition: HIV; HIV Infections; AIDS; Antiretroviral Therapy

NCT ID: NCT01645865

Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission

Condition: HIV Infection; Herpes Simplex, Genital; Sexually Transmitted Diseases

NCT ID: NCT00194519

Safety and Effectiveness of Tenofovir 1% Gel, Tenofovir Disproxil Fumarate, and Emtricitabine/Tenofovir Disoproxil Fumarate Tablets in Preventing HIV in Women

Condition: HIV Infections

NCT ID: NCT00705679

Psychosocial Needs of YMSM

Condition: HIV+ YMSM

NCT ID: NCT00710671

TMC278-TiDP6-C215: A Clinical Trial in Treatment Naive HIV-subjects Patients Comparing TMC278 to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors

Condition: HIV Infections; HIV-1

NCT ID: NCT00543725

Project UNITY - HIV Risk Reduction and Vaccine Education Interventions

Condition: HIV Infections; Hepatitis B

NCT ID: NCT00150098

Primary Care-Based Interventions to Reduce Alcohol Use Among HIV Patients

Condition: HIV; Acquired Immunodeficiency Syndrome; Alcoholism; Alcoholic Intoxication; Substance-Related Disorders

NCT ID: NCT01671501

Efavirenz and Lamivudine/Zidovudine for Treatment-Naive HIV Infected People in Wenxi County, Shanxi Province, China

Condition: HIV Infections

NCT ID: NCT00100594

BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1.

Condition: HIV Infections

NCT ID: NCT00326963

Healthy Choices to Promote Health and Reduce Risk in HIV-Infected Youth

Condition: HIV Infection

NCT ID: NCT00103532

Pediatric HIV Disclosure Intervention

Condition: Paediatric HIV Diagnosis Disclosure

NCT ID: NCT01773642

Pharmacotherapy for HIV Infected Patients With Alcohol Problems

Condition: HIV Infection; Heavy Alcoholic Consumption; HIV Infections

NCT ID: NCT00854230

Gentian Violet Vs. Nystatin Oral Suspension for Treatment of Oropharyngeal Candidiasis

Condition: HIV-1 Infection

NCT ID: NCT01427738

Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00120510

Micronutrients and Antioxidants in HIV Infection

Condition: HIV Infection

NCT ID: NCT00798772

Reduction of EArly mortaLITY in HIV-infected Adults and Children Starting Antiretroviral Therapy

Condition: Human Immunodeficiency Virus

NCT ID: NCT01825031

Intermittent Therapy in HIV-1 Infected Patients With Successful Viral Suppression Under Highly Active Antiretroviral Therapy (HAART)

Condition: HIV Infections

NCT ID: NCT00122551

Facial Lipoatrophy Trial: Immediate Versus Deferred Injections of Poly-L-Lactic Acid for HIV Facial Lipoatrophy

Condition: HIV-Associated Lipodystrophy; HIV Infections

NCT ID: NCT00126308

A Long-term Follow-up of the HIV-NAT Cohort

Condition: HIV Infections

NCT ID: NCT00411983

SONETT: Switch Study to Once Daily HIV Treatment Regimen With Truvada

Condition: HIV-1 Infection

NCT ID: NCT00323687

Comparison of Anti-HIV Drug Combinations to Prevent Mother-to-Child Transmission of HIV

Condition: HIV Infections

NCT ID: NCT00086359

Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136

Condition: HIV Infections

NCT ID: NCT00421551

Integration of HIV Care and Treatment Into Antenatal Care in Migori District, Kenya

Condition: HIV Infections

NCT ID: NCT00931216

Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-Infected Patients in Virological Failure.

Condition: HIV Infections

NCT ID: NCT00196625

Once-daily Highly Active Antiretroviral Treatment Regimen Administration in HIV-1 Infected Children in Burkina Faso (ANRS 12103 BURKINAME)

Condition: HIV Infections; AIDS

NCT ID: NCT00122538

ONCE - Only Nocturnal Combination Evaluation of Antiretroviral-Experienced HIV 1 Infected Subjects Switching to Atripla

Condition: HIV Infections

NCT ID: NCT00615745

Extended Safety Study of Tenofovir Disoproxil Fumarate (TDF) Among HIV-1 Negative Men

Condition: HIV Infection

NCT ID: NCT00131677

Testing a Secondary Prevention Intervention for HIV-Positive Black Young Men Who Have Sex With Men

Condition: HIV; AIDS

NCT ID: NCT01751594

HIV Non-Occupational Post-Exposure Prophylaxis

Condition: Human Immunodeficiency Virus

NCT ID: NCT01855867

FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women

Condition: HIV Infections

NCT ID: NCT00625404

National Evaluation of PI-based 2nd Line Efficacy in Cambodia

Condition: HIV

NCT ID: NCT01801618

Safety and Acceptability Study of Non-occupational Prophylaxis (PEP) Following Potential Exposure to HIV

Condition: HIV

NCT ID: NCT01602822

Comparative Study of Three NNRTI-Sparing HAART Regimens

Condition: HIV Infection

NCT ID: NCT00811954

Not yet recruiting(En español)

Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women

Condition: HIV Infections; Tuberculosis

NCT ID: NCT01494038

Tuberculosis Prevention for HIV Infected Adults

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00057122

KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects

Condition: Infection, Human Immunodeficiency Virus I; HIV Infection

NCT ID: NCT00549198

Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda

Condition: HIV Infections

NCT ID: NCT00674921

Safety and Antiviral Activity of TPV in HCV and/or HBV HIV Coinfected Patients TDM Randomised Pilot Evaluation

Condition: HIV Infections

NCT ID: NCT00447902

SPRING: Safety, Efficacy, Pharmacokinetics of tipRanavir/r IN Race/Gender HIV+ Patients Randomized to TDM or SoC

Condition: HIV Infections

NCT ID: NCT00440271

Optimizing Treatment for Treatment-Experienced, HIV-infected People

Condition: HIV Infections

NCT ID: NCT00537394

Study to Determine the Pharmacokinetic Behavior of Antiretroviral Drugs in Patients Infected by HIV

Condition: HIV Infections

NCT ID: NCT00307502

Evaluation of the Cellular Pharmacology of Tenofovir and Emtricitabine According to HIV Infection Status

Condition: HIV Infections

NCT ID: NCT01040091

Early HIV Therapy in Patients With High CD4 Cell Counts

Condition: HIV

NCT ID: NCT01479634

Examining Benefits of HAART Continuation in Postpartum Mothers

Condition: HIV Infections

NCT ID: NCT00955968

The Effect of Low-Dose Human Growth Hormone Therapy in HIV Infected Patients

Condition: HIV Infections; Lipodystrophy

NCT ID: NCT00119769

Effects of Two Anti-HIV Drug Regimens on HIV Transmission Risk Behavior Among SMART Study Participants

Condition: HIV Infections

NCT ID: NCT00386035

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1: Tenofovir + Emtricitabine + Lopinavir/Ritonavir Versus Tenofovir + Emtricitabine + Raltegravir (RAL-PEP)

Condition: HIV Infection

NCT ID: NCT01576731

Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA)

Condition: HIV Infection; Tuberculosis

NCT ID: NCT00226434

Attitudes and Beliefs and the Steps of HIV Care

Condition: Human Immunodeficiency Virus Infections

NCT ID: NCT00749840

Nevirapine vs. Atazanavir Boosted With Ritonavir on a Background of Truvada in Human Immunodeficiency Virus (HIV) Infected Naive Patients (NEwArT)

Condition: HIV Infections

NCT ID: NCT00552240

Safety and Effectiveness of Raltegravir Plus Darunavir/Ritonavir in Treatment-Naive HIV-Infected Adults

Condition: HIV-1 Infections

NCT ID: NCT00830804

When to Start Anti-HIV Drugs in Children Infected With HIV (The PREDICT Study)

Condition: HIV Infections

NCT ID: NCT00234091

HIV-HBV Co-Infection and Liver Disease

Condition: HIV Infections; HIV-HBV Co-Infection

NCT ID: NCT00637429

Study Comparing Two Alternatives of Antiretroviral Therapy as Post-exposure Prophylaxis to HIV-1:FOVIR+EMTRICITABINA + LOPINAVIR/RITONAVIR VS TENOFOVIR+EMTRICITABINA + MARAVIROC (MARAVI-PEP)

Condition: HIV Infection

NCT ID: NCT01533272

A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected Patients

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00398996

A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa

Condition: HIV Infections

NCT ID: NCT01337570

A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa

Condition: HIV Infections

NCT ID: NCT01337583

Raltegravir Switch for Toxicity or Adverse Events

Condition: HIV/AIDS; Antiretroviral Therapy; HIV Infections

NCT ID: NCT00958100

"The Once A Day Protease Inhibitor Regimens"

Condition: HIV Infections; Antiretroviral Therapy

NCT ID: NCT00242216

Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy

Condition: HIV Infections; Pregnancy

NCT ID: NCT00017719

Pharmacokinetics of Atazanavir/Ritonavir in HIV-1 Infected Pregnant Women

Condition: HIV Infection

NCT ID: NCT00326716

A Safety Study of Dapivirine Vaginal Ring in Africa

Condition: HIV Infections

NCT ID: NCT01071174

Intensification With Enfuvirtide in Naive HIV-infected Patients (ANRS130)

Condition: HIV Infections; AIDS

NCT ID: NCT00302822

Long-Term Data Collection From Participants in Adult AIDS Clinical Trials

Condition: HIV Infections

NCT ID: NCT00001137

Study on the Effect of Kaletra + Nevirapine as Maintenance Bitherapy Compared to a Triple Therapy Including Kaletra + Analogues in HIV Patients

Condition: HIV Infections

NCT ID: NCT00335686

Immuno-Virological Efficacy of Combination With Trizivir +Tenofovir in Multiresistant HIV Patients

Condition: HIV Infections

NCT ID: NCT00356616

BATAR: Individuals Currently Taking Boosted Atazanavir as Part of an HIV Treatment Regimen Will be Evaluated to See if Substituting Raltegravir for Nucleoside Transcriptase Inhibitors Will be Safe and Well Tolerated.

Condition: HIV

NCT ID: NCT00931801

Optimizing Pediatric HIV-1 Treatment, Nairobi, Kenya

Condition: HIV Infections

NCT ID: NCT00428116

4-Day-A-Week Treatment Plan for HIV Infected Adolescents

Condition: HIV Infections

NCT ID: NCT00068809

Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities

Condition: HIV Infections

NCT ID: NCT00255840

Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV

Condition: HIV Infections

NCT ID: NCT00122512

Efficacy of HIV Post-Test Support for ANC in South Africa

Condition: HIV; Acquired Immunodeficiency Syndrome

NCT ID: NCT01683461

Mentor Mothers: A Sustainable Family Intervention in South African Townships

Condition: Human Immunodeficiency Virus; Acquired Immune Deficiency Syndrome; Tuberculosis

NCT ID: NCT00972699

A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)

Condition: HIV Infection

NCT ID: NCT00094367

Breastfeeding, Antiretroviral, and Nutrition Study

Condition: HIV Infections

NCT ID: NCT00164736

Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen

Condition: HIV Infections

NCT ID: NCT00135369

Parent-Provider Intervention for Improving Medication Adherence in Children With Attention Deficit Hyperactivity Disorder

Condition: Attention Deficit Disorder With Hyperactivity

NCT ID: NCT00429221

Safety and Acceptability of a Vaginal Microbicide

Condition: HIV Infections; Hepatitis B, Chronic

NCT ID: NCT00111943

Study of Pharmacokinetics in HIV-infected Women

Condition: HIV Infections

NCT ID: NCT00433979

A Study to Compare Effectiveness and Safety of Darunavir/Ritonavir (DRV/Rtv) 800mg/100mg Once Daily Versus DRV/Rtv 600mg/100mg Twice Daily in Early Treatment-Experienced HIV-1 Infected Patients (ODIN)

Condition: Human Immunodeficiency Virus - Type 1

NCT ID: NCT00524368

Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy

Condition: HIV Infections; Tuberculosis

NCT ID: NCT00476853

Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy

Condition: HIV Disease

NCT ID: NCT01338025

BMS-Reyataz Study in Treatment in Naive Subjects to Compare the Efficacy and Safety Between Boosted Reyataz and Kaletra When in Combination With Fixed Dose Truvada

Condition: HIV Infections

NCT ID: NCT00272779

Clinical Trial to Assess the Security of the Dose Reduction of Ritonavir in HIV-Infected Patients in Treatment With Tipranavir/Ritonavir 500/200 mg Every 12 Hours

Condition: HIV Infections

NCT ID: NCT00607958

Aging & HIV/AIDS Neurocognitive Sequelae and Functional Consequences

Condition: HIV Infections

NCT ID: NCT00675766

Intermittent Versus Continuous HAART (Highly Active Antiretroviral Therapy) for Treating Chronic HIV Infected Patients in Uganda

Condition: HIV

NCT ID: NCT00339456

Safety and Effectiveness of World Health Organization Dosing Guidelines of Lopinavir/Ritonavir for Children

Condition: HIV

NCT ID: NCT01172535

Study To Evaluate Long Term Maintenance With TRIZIVIR After Boosted Protease Inhibitor (PI) Or Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI) In HIV-1 Infected Adults

Condition: HIV Infections

NCT ID: NCT00449436

Renal, Endocrine, and Bone Changes in Response to TDF/FTC in Uninfected YMSM.

Condition: HIV Infection

NCT ID: NCT01769469

A Phase IIIb Study Comparing Two Boosted Protease Inhibitor-based HAART Regimens in HIV-infected Patients Experiencing Their First Virologic Failure While Receiving an NNRTI-containing HAART Regimen

Condition: HIV Infections

NCT ID: NCT00135395

Study to Evaluate the Effectiveness of ABC+3TC +EFV in Once-Daily Regimens Versus KLT in Twice-Daily Regimens in Naive HIV Patients

Condition: HIV Infections

NCT ID: NCT00318123

Interventions to Decrease the Risk of Mother-to-Child Transmission of HIV in India

Condition: HIV-1

NCT ID: NCT00341796

Community-based Accompaniment With Supervised Antiretrovirals in Lima, Peru

Condition: HIV; AIDS; HIV Infections

NCT ID: NCT01070017

Randomized Controlled Trial of Stress Management Training in HIV

Condition: HIV Infections

NCT ID: NCT00436085

Saquinavir/Ritonavir in Single Therapy as Maintenance Treatment

Condition: HIV Infections

NCT ID: NCT00379405

Antiretroviral Treatment Simplified Follow-up Management Assessment (ANRS 12110 STRATALL)

Condition: HIV Infections; AIDS

NCT ID: NCT00301561

The Use of Leukapheresis to Support HIV Pathogenesis Studies

Condition: HIV

NCT ID: NCT01161199

Directly Administered Antiretroviral Therapy (DAART) Among HIV-1infected Injecting Drug Users (IDUs) in Chennai, India

Condition: HIV Infections; Heroin Dependence

NCT ID: NCT00709007

A 48-Week, Randomised, Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation: the ASK-500 Study

Condition: HIV Infections

NCT ID: NCT00192608

Trial of Ibudilast for Methamphetamine Dependence

Condition: Methamphetamine Dependence; HIV Infection

NCT ID: NCT01860807

Evaluating a Structural and Behavioral HIV Risk Reduction Program for Black Men

Condition: HIV

NCT ID: NCT01694121

FOTO: Five Consecutive Days on Treatment With Efavirenz, Tenofovir, and Emtricitabine Followed by Two Days Off Treatment Versus Continuous Treatment

Condition: HIV Infections

NCT ID: NCT00414635

Efficacy and Safety of Kaletra Monotheraphy Compared to Kaletra Based Triple Therapy to Treat HIV in Antiretroviral Naїve Patients

Condition: HIV Infection

NCT ID: NCT00234923

Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects

Condition: HIV Infection

NCT ID: NCT00297076

Comparison of Liquid Kaletra and Low Dose Kaletra Tablets

Condition: HIV Infections

NCT ID: NCT00762320

Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5-Tropic Treatment-Experienced HIV-Infected Subjects

Condition: HIV Infection

NCT ID: NCT00197145

Pediatric Nevirapine Resistance Study

Condition: AIDS; HIV Infections

NCT ID: NCT00117728

Atazanavir and Lamivudine for Treatment Simplification

Condition: HIV Infections

NCT ID: NCT00885482

Pilot Simplification Study to Lopinavir/Ritonavir 800/200 mg Monotherapy Regimen Once Daily

Condition: HIV

NCT ID: NCT01581853

Safety Study of Raltegravir in HIV/HCV Co-infected Patients

Condition: HIV; Hepatitis C

NCT ID: NCT01225705

Safety and Pharmacokinetics of Dapivirine/Maraviroc Vaginal Ring

Condition: HIV Infections

NCT ID: NCT01363037

Switch to Darunavir/r + Maraviroc QD in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA)

Condition: HIV Infection

NCT ID: NCT01367210

Meaning of Life in HIV-infected Youths

Condition: Meaning of Life

NCT ID: NCT01644383

NNRTI/PI Toxicity Switch to Darunavir Study

Condition: HIV

NCT ID: NCT00765154

Implementation Effectiveness and Safety of Tenofovir Gel Provision Through Family Planning Services

Condition: HIV

NCT ID: NCT01691768

The Self-Collection Study: a Study of Self-collected HPV Testing and Results Counseling

Condition: HIV Infection

NCT ID: NCT01843478

Evaluation of Atazanavir Substitution Intervention (EASI) Study

Condition: HIV Infections

NCT ID: NCT00247845

Three Chemo Regimens as an Adjunct to ART for Treatment of Advanced AIDS-KS

Condition: HIV-1 Infection

NCT ID: NCT01435018

Atazanavir/Ritonavir Maintenance Therapy

Condition: HIV Infections

NCT ID: NCT00084019

Rapid Initiation of Antiretroviral Therapy to Promote Early HIV/AIDS Treatment in South Africa (RapIT Study)

Condition: HIV

NCT ID: NCT01710397

Trial of Citalopram for the Prevention of Depression

Condition: Depression; HIV Infections; Hepatitis C

NCT ID: NCT00317746

Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once Daily

Condition: HIV Infections

NCT ID: NCT00314626

Raltegravir and Atazanavir Replacing Current Suppressive Treatment Because of Side Effects in Current Treatment

Condition: HIV Infections

NCT ID: NCT00751153

Tenofovir Gel in Pregnancy and Lactation

Condition: HIV Infections

NCT ID: NCT01136759

Mother-Infant Rapid Intervention at Delivery Telephone Outreach for Neonatal Therapy (TOT) Trial.

Condition: HIV

NCT ID: NCT00139087

A Multicentre Trial of Second-line Antiretroviral Treatment Strategies in African Adults Using Atazanavir or Lopinavir/Ritonavir

Condition: HIV

NCT ID: NCT01255371

Evolution of L74V or K65R Mutations in VIremic Subjects on Tenofovir Disoproxil Fumarate (TDF) or Abacavir (ABC) (EVITA)

Condition: HIV Infections

NCT ID: NCT00312169

A Trial of 2 Options for Second Line Combination Antiretroviral Therapy Following Virological Failure of a Standard Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)+2N(t)RTI First Line Regimen

Condition: HIV Infections

NCT ID: NCT00931463

Adding Maraviroc to Antiretroviral Therapy for Suboptimal CD4 T-Cell Recovery Despite Sustained Virologic Suppression

Condition: HIV Infections

NCT ID: NCT00709111

Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy

Condition: HIV Infections

NCT ID: NCT00611039

A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL Study

Condition: HIV Infections

NCT ID: NCT00192634

Virologic and Immunologic Activity of Continued Lamivudine (3TC) vs Delavirdine (DLV) in Combination With Indinavir (IDV) and Zidovudine (ZDV) or Stavudine (d4T) in 3TC-Experienced Subjects

Condition: HIV Infections

NCT ID: NCT00000882

Clinical Trial, Open-label, Randomised, in Order to Compare the Quality of Life for Those VIH+ Patients That Start With Monotherapy on LPV/r Tablets Vs. Triple Therapy With a Boosted Protease Inhibitor

Condition: HIV Infection

NCT ID: NCT01166477

Positively Smoke Free on the Web (PSFW) for Smokers Living With HIV

Condition: Tobacco Use Cessation; Tobacco Cessation; Tobacco Use Disorder; Tobacco Dependence; Tobacco-Use Disorder; Virus, Human Immunodeficiency

NCT ID: NCT01570595

Lopinavir/r Monotherapy as Maintenance Therapy After Long Term Viral Suppression

Condition: HIV Infections

NCT ID: NCT00160849

Conditional Cash Transfers to Increase Uptake of and Retention of PMTCT Services

Condition: HIV

NCT ID: NCT01838005

Risky Decision Making in Methamphetamine Users: The Role of Opioid Blockade

Condition: Methamphetamine Abuse; HIV

NCT ID: NCT01822132

Adopting and Demonstrating the Adaptation of Prevention Techniques: Community PROMISE PLUS

Condition: HIV Prevention; STD Prevention

NCT ID: NCT00267436

A Study to Evaluate the Bioequivalence of a Combined Formulated Tablet Compared With Maraviroc and Combivir™

Condition: Infection, Human Immunodeficiency Virus I

NCT ID: NCT01597648

Reducing Unsafe Alcohol Use in HIV-Positive Individuals

Condition: Alcohol Abuse

NCT ID: NCT00371969

Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent Patients

Condition: Opioid Dependence; Hepatitis; HIV

NCT ID: NCT01645033

Management of Hepatitis C in HIV Infected Injection Drug Users (IDUs)

Condition: HIV Infection; Hepatitis C

NCT ID: NCT01448915

Behavioral Therapy Development for Methamphetamine Abusers

Condition: The Study Was Designed to Develop a Cognitive Behavioral Approach to Treating Methamphetamine Abuse in HIV Primary Care Settings.

NCT ID: NCT00249678

Suspended

HIV Risk Reduction and Drug Abuse Treatment in Iran

Condition: Opiate Dependence; HIV Infections

NCT ID: NCT00398008

Psychiatric Problems in Children and Adolescents Infected With HIV at Birth

Condition: HIV Infections; Mental Disorders

NCT ID: NCT00100542

Effectiveness of a Risk Reduction Program in Preventing the Transmission of HIV and Sexually Transmitted Diseases in African-American Couples

Condition: HIV Infections; Sexually Transmitted Disease

NCT ID: NCT00644163

Integrated Care Centers to Improve HIV Outcomes in Vulnerable Indian Populations

Condition: HIV Infection

NCT ID: NCT01686750

Differences Between Stavudine and Tenofovir Each Combined With Lamivudine and Efavirenz in SA HIV-infected Patients

Condition: Mitochondrial Toxicity; Metabolic Complications

NCT ID: NCT01601899

Methadone Maintenance Treatment (MMT) Care for HIV Prevention

Condition: Stigma

NCT ID: NCT01760720

Integrated Stepped Care for Unhealthy Alcohol Use in HIV

Condition: Liver Diseases, Alcoholic; Alcoholism; HIV; Hepatitis C

NCT ID: NCT01410123

To Assess Compliance With a Once-daily Regimen of Lamivudine, Efavirenz and Didanosine

Condition: AIDS

NCT ID: NCT00207168

Reducing Drug Use and HIV Risk in Drug-dependent Adults Arrested for Prostitution

Condition: Substance-related Disorders; HIV Risk Behavior

NCT ID: NCT01560221

Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users

Condition: HIV; AIDS; Substance Abuse; Inpatient

NCT ID: NCT01612169

Reducing High Risk Behavior in Drug Court

Condition: Substance Abuse; HIV

NCT ID: NCT01481428

Minority AIDS Initiative Retention and Re-Engagement Project

Condition: HIV/AIDS

NCT ID: NCT01616940

Intensive Models of HCV Care for Injection Drug Users

Condition: Hepatitis C; Medication Adherence

NCT ID: NCT01857245

Comparison of Facility and Home-based ART Delivery Systems in Uganda

Condition: AIDS

NCT ID: NCT00144365

China Adherence Through Technology Study

Condition: Medication Adherence

NCT ID: NCT01722552

Nurse Delivered Cell Phone Adherence Intervention (Pick It UP)

Condition: Medication Adherence

NCT ID: NCT01359280

Pre-exposure Prophylaxis Adherence Intervention for MSM

Condition: Medication Adherence

NCT ID: NCT01632397

Adherence, Improvement Measure (AIM) System

Condition: Patient Compliance; AIDS

NCT ID: NCT01252212

Safety Study of Fluconazole in Combination With Flucytosine for the Treatment of Early Cryptococcal Infection

Condition: Cryptococcal Infection Disseminated

NCT ID: NCT01562132

62% & 15% Ethanol in Emollient Gel as Topical Male Microbicides

Condition: Sexually Transmitted Infections

NCT ID: NCT00469547